-
Dissecting the shared genetic architecture of ADHD and substance use disorders: Promising leads and persistent challenge
Author: Xu, Siyao; Zhou, Hongfei
Journal: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2026; Vol. 109, Issue , pp. -. DOI: 10.1016/j.euroneuro.2026.112823
-
Revisiting the earlier, pre-CHR-P prodrome of psychotic illness: a desideratum for advancing early intervention
Author: Nkire, Nnamdi; Kinsella, Anthony; Russell, Vincent; Waddington, John L
Journal: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2026; Vol. 109, Issue , pp. -. DOI: 10.1016/j.euroneuro.2026.112825
-
Selective reinforcement learning deficits in antipsychotic-naive patients with first-episode schizophrenia-spectrum disorde
Author: Chu, Ryan Sai Ting; Waltz, James A.; Gold, James M.; Wo, Sui Fung; Wong, Cheuk Fei; Hui, Christy Lai Ming; Chan, Sherry Kit Wa; Lee, Edwin Ho Ming; Lui, Simon Sai Yu; Chen, Eric Yu Hai; Chang, Wing Chung
Journal: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2026; Vol. 109, Issue , pp. -. DOI: 10.1016/j.euroneuro.2026.112824
-
Adopting a dual-track inclusion strategy aligned with DSM-5 clinical diagnosis to enhance the clinical translatability of study finding
Author: Tang, Hongmei; Zhang, Yujie; Pu, Yuting; Bai, Xue
Journal: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2026; Vol. 108, Issue , pp. -. DOI: 10.1016/j.euroneuro.2026.112819
-
Unraveling the genetic architecture of depression-atherosclerosis comorbidity: a paradigm shift in understanding mind-heart connection
Author: Ma, Jisheng; Lin, Nan
Journal: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2026; Vol. 107, Issue , pp. -. DOI: 10.1016/j.euroneuro.2026.112806
-
Methodological points for consideration: Enhancing the interpretation of the COH-FIT finding
Author: Hu, Jue; Xuan, Xiao-bo; Chen, Jian; Ma, Jing-ying
Journal: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2026; Vol. 107, Issue , pp. -. DOI: 10.1016/j.euroneuro.2026.112803
-
Critical considerations on the trial of FAAH inhibitor JNJ-42165279 in major depressive disorder with anxious distres
Author: Hu, Jue; Ma, Jing-ying; Xuan, Xiao-bo; Chen, Jian
Journal: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2026; Vol. 107, Issue , pp. -. DOI: 10.1016/j.euroneuro.2026.112804
-
Comment on All-cause and cause-specific mortality in people with mental disorders: a population-based study on risk evaluation, effect modifiers and excess life-years lost in Hong Kon
Author: Xia, Hailun; Yang, Yuanyi
Journal: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2026; Vol. 106, Issue , pp. -. DOI: 10.1016/j.euroneuro.2026.112781
